Delcath Systems (STU:DV3R) 5-Year EBITDA Growth Rate : 61.70% (As of Dec. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Delcath Systems 5-Year EBITDA Growth Rate?

Delcath Systems's EBITDA per Share for the three months ended in Dec. 2024 was €0.31.

During the past 3 years, the average EBITDA Per Share Growth Rate was 49.90% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 61.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Delcath Systems was 77.10% per year. The lowest was 34.30% per year. And the median was 62.95% per year.

Competitive Comparison of Delcath Systems's 5-Year EBITDA Growth Rate

For the Medical Devices subindustry, Delcath Systems's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Delcath Systems's 5-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Delcath Systems's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Delcath Systems's 5-Year EBITDA Growth Rate falls into.

Delcath Systems 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Delcath Systems (STU:DV3R) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Delcath Systems 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Delcath Systems's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Delcath Systems Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Delcath Systems Inc (STU:DV3R) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

DCTH:USA DV3R:Germany

Address

566 Queensbury Avenue, Queensbury, NY, USA, 12804

Website

https://www.delcath.com

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Delcath Systems Headlines

No Headlines